OneMedNet Corporation (ONMD) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

OneMedNet Corporation (ONMD) Healthcare & Pipeline Overview

OneMedNet Corporation provides clinical imaging solutions, utilizing its iRWD platform to apply AI in de-identifying and curating imaging data. Serving medical and academic research institutions, the company facilitates advancements in medical research, discovery, and diagnostics within the life sciences sector, despite current negative profitability margins.

What Is the Investment Thesis for ONMD?

OneMedNet Corporation operates in the growing healthcare information services sector, providing AI-driven clinical imaging solutions. The iRWD platform's ability to de-identify and curate imaging data offers a valuable service to medical and academic research institutions. However, the company's negative profit margin of -206.1% and gross margin of -37.0% raise concerns about its financial sustainability. The company's small market capitalization of $38.0M also indicates a high-risk investment. Future growth hinges on expanding its customer base and achieving profitability through efficient operations and strategic partnerships. The company's beta of 1.17 suggests a slightly higher volatility compared to the market.

Based on FMP financials and quantitative analysis

ONMD Key Highlights

Market capitalization of $38.0M, indicating a micro-cap company.

• Negative profit margin of -206.1%, reflecting significant losses.
• Negative gross margin of -37.0%, suggesting challenges in cost management.
• iRWD platform utilizes AI to de-identify and curate imaging data.
• Beta of 1.17, indicating slightly higher volatility compared to the market.

Who Are ONMD's Competitors?

ONMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are ONMD's Key Strengths?

Proprietary iRWD platform with AI capabilities

• Expertise in data de-identification and curation
• Focus on serving medical and academic research institutions
• Potential to accelerate medical research and diagnostics

What Are ONMD's Weaknesses?

Negative profit margin and gross margin

• Small market capitalization
• Limited financial resources
• Dependence on a small team of employees

What Could Drive ONMD Stock Higher?

Expansion of partnerships with medical research institutions to drive iRWD platform adoption.

• Development and integration of advanced AI algorithms into the iRWD platform for enhanced image analysis.
• Potential regulatory approvals for new data analytics services, expanding market reach.
• Focus on securing additional funding to support growth initiatives and improve financial stability.

What Are the Key Risks for ONMD?

Listing risk — at $0.6665 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Negative profit margin and gross margin pose a threat to financial sustainability.
• Competition from larger, more established players in the healthcare IT space.
• Regulatory changes and data security concerns could impact the iRWD platform's compliance.
• Economic downturn and reduced research funding could limit growth opportunities.
• Technological advancements could render the iRWD platform obsolete.

What Are the Growth Opportunities for ONMD?

• Expansion of iRWD Platform Capabilities: OneMedNet can enhance its iRWD platform by integrating advanced AI algorithms for image analysis and diagnostics. This would attract a broader range of research institutions and pharmaceutical companies seeking comprehensive imaging solutions. The market for AI in medical imaging is projected to reach $3.5 billion by 2028, offering a significant growth opportunity for OneMedNet. Timeline: 1-2 years.
• Strategic Partnerships with Research Institutions: Collaborating with leading medical and academic research institutions can provide OneMedNet with access to valuable data and expertise. These partnerships can also serve as case studies to demonstrate the effectiveness of the iRWD platform, attracting new customers. The market for research collaborations in healthcare is estimated at $10 billion annually. Timeline: Ongoing.
• Geographic Expansion into New Markets: OneMedNet can expand its operations beyond the United States by targeting international markets with high demand for clinical imaging solutions. This would diversify its revenue streams and reduce its reliance on the domestic market. The global market for healthcare IT is projected to reach $390 billion by 2027. Timeline: 2-3 years.
• Development of New Data Analytics Services: OneMedNet can leverage its expertise in data de-identification and curation to develop new data analytics services for the healthcare industry. This could include providing customized data reports, predictive analytics, and data-driven insights to help healthcare providers improve patient outcomes. The market for healthcare analytics is projected to reach $75 billion by 2028. Timeline: 1-2 years.
• Focus on Regulatory Compliance and Data Security: As the healthcare industry becomes increasingly regulated, OneMedNet can differentiate itself by prioritizing regulatory compliance and data security. This would build trust with customers and attract organizations that require robust data protection measures. The market for healthcare cybersecurity is projected to reach $25 billion by 2027. Timeline: Ongoing.

What Are ONMD's Competitive Advantages?

• Proprietary iRWD platform with AI-driven capabilities.
• Expertise in data de-identification and curation.
• Established relationships with medical and academic research institutions.

What Does ONMD Do?

OneMedNet Corporation, based in Eden Prairie, Minnesota, specializes in clinical imaging solutions. The company's core offering is iRWD, a platform that leverages artificial intelligence to securely de-identify, search, and curate imaging data. This technology is primarily aimed at supporting a network of medical and academic research institutions. By facilitating efficient data management and analysis, OneMedNet aims to accelerate progress in medical research, discovery, and diagnostics across various life science domains. The iRWD platform enables researchers to access and utilize imaging data more effectively, addressing a critical need in the healthcare industry. The company focuses on providing tools that enhance data utility while maintaining patient privacy, a crucial aspect of handling sensitive medical information. OneMedNet's solutions are designed to streamline the research process, allowing institutions to focus on innovation and development. The company currently manages its operations with a team of 22 employees. OneMedNet's business model centers around providing advanced data solutions to the medical research community, positioning itself as a key enabler of cutting-edge research and diagnostic advancements. While the company's history and founding details are not fully available, its current focus is clearly on leveraging AI to transform clinical imaging data management.

What Products and Services Does ONMD Offer?

• Provides clinical imaging solutions to healthcare organizations.
• Offers the iRWD platform for AI-driven data de-identification and curation.
• Serves medical and academic research institutions.
• Facilitates advancements in medical research and diagnostics.
• Enables efficient data management and analysis.
• Supports data utility while maintaining patient privacy.
• Streamlines the research process for healthcare institutions.

How Does ONMD Make Money?

• Provides subscription-based access to the iRWD platform.
• Offers customized data analytics services to healthcare providers.
• Generates revenue through strategic partnerships with research institutions.

What Industry Does ONMD Operate In?

OneMedNet Corporation operates within the healthcare information services industry, a sector experiencing growth driven by the increasing digitization of medical data and the demand for advanced analytics. The market for AI-driven healthcare solutions is expanding, with research institutions and pharmaceutical companies seeking efficient ways to manage and analyze clinical data. OneMedNet's iRWD platform addresses this need by providing tools for data de-identification and curation. However, the company faces competition from larger, more established players in the healthcare IT space, requiring it to demonstrate a clear competitive advantage to gain market share.

Who Are ONMD's Key Customers?

• Medical research institutions
• Academic research institutions
• Pharmaceutical companies
• Healthcare providers

Company Profile

OneMedNet Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Eden Prairie, US. The company is led by CEO Aaron Green. ONMD has traded publicly since 2021.

Return on equity for OneMedNet Corporation stands at 90.5%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -18.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.27 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -8.5%, the inverse of the P/E and a quick read on earnings relative to price.

ONMD Valuation & Market Position

With a $38.0M market cap, OneMedNet Corporation sits in the micro-cap segment of the market. Relative to its peer group, ONMD's quantitative score of 21/100 is below the peer average of 66/100.

Quarterly Financial Performance: OneMedNet Corporation

Revenue for OneMedNet Corporation came in at $292K during Q2 FY2026, a 204.2% improvement versus the preceding quarter. The company recorded a net loss of $2.2M, with diluted EPS of $-0.04. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, ONMD averaged $-0.04 in diluted EPS.

OneMedNet Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

Over the past six months, OneMedNet Corporation insiders filed 11 SEC Form 4 transactions — 0 sales and 11 purchases. On net that is roughly 3.7M shares acquired (about $2.8M) — insiders putting money in tends to read as conviction.

ONMD Financials

ONMD Latest News

ONMD Analyst Consensus

ONMD MoonshotScore

ONMD Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources